Editas Medicine, Inc. (EDIT) Profit Margin
Editas Medicine, Inc. (EDIT) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | -1605.53% |
| 2017-12-31 | -876.49% |
| 2018-12-31 | -344.28% |
| 2019-12-31 | -651.43% |
| 2020-12-31 | -127.82% |
| 2021-12-31 | -753.61% |
| 2022-12-31 | -1118.26% |
| 2023-12-31 | -196.13% |
| 2024-12-31 | -733.74% |
| 2025-12-31 | -395.11% |
How EDIT compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc. | -125.36% |
| SNDX | Syndax Pharmaceuticals Inc. | -165.60% |
| AQST | Aquestive Therapeutics Inc. | -188.09% |
| VERU | Veru Inc. | -223.86% |
| DYAI | Dyadic International Inc. | -238.31% |
These are five companies in the same sector as EDIT with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Editas Medicine, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("EDIT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | EDIT | $3.23 | +4.87% | 1.39M |
| 3 | ||||
| 4 | ||||
| 5 |